PT1155013E - Compostos heterociclicos de benzenossulfonamida como antagonistas da bradiquinina - Google Patents

Compostos heterociclicos de benzenossulfonamida como antagonistas da bradiquinina

Info

Publication number: PT1155013E
Authority: PT; Portugal
Prior art keywords: bradiquinin; benzenosulfonamide; antagonists; heterocyclic compounds; heterocyclic
Prior art date: 1999-02-26

Application number

PT00906414T

Other languages

English (en)

Inventor

Pierre Dodey

Michel Bondoux

Martine Barth

Original Assignee

Fournier Ind & Sante

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-26

Filing date

2000-02-17

Publication date

2003-12-31

2000-02-17 Application filed by Fournier Ind & Sante filed Critical Fournier Ind & Sante

2003-12-31 Publication of PT1155013E publication Critical patent/PT1155013E/pt

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

PT00906414T 1999-02-26 2000-02-17 Compostos heterociclicos de benzenossulfonamida como antagonistas da bradiquinina PT1155013E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9902412A FR2790260B1 (fr)	1999-02-26	1999-02-26	Nouveaux composes de n-(benzenesulfonamide), procede de preparation et utilisation en therapeutique

Publications (1)

Publication Number	Publication Date
PT1155013E true PT1155013E (pt)	2003-12-31

Family

ID=9542576

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT00906414T PT1155013E (pt)	1999-02-26	2000-02-17	Compostos heterociclicos de benzenossulfonamida como antagonistas da bradiquinina

Country Status (31)

Country	Link
US (1)	US6479515B1 (pt)
EP (1)	EP1155013B1 (pt)
JP (1)	JP4564666B2 (pt)
KR (1)	KR20010102057A (pt)
CN (1)	CN1340050A (pt)
AR (1)	AR022754A1 (pt)
AT (1)	ATE245640T1 (pt)
AU (1)	AU2809600A (pt)
BG (1)	BG105840A (pt)
BR (1)	BR0008221A (pt)
CA (1)	CA2371853C (pt)
CZ (1)	CZ303169B6 (pt)
DE (1)	DE60004017T2 (pt)
DK (1)	DK1155013T3 (pt)
EE (1)	EE04839B1 (pt)
ES (1)	ES2202059T3 (pt)
FR (1)	FR2790260B1 (pt)
HK (1)	HK1041267A1 (pt)
HR (1)	HRP20010619A2 (pt)
HU (1)	HUP0200281A3 (pt)
ID (1)	ID29914A (pt)
IL (1)	IL144720A0 (pt)
MX (1)	MXPA01008672A (pt)
NO (1)	NO20014048D0 (pt)
NZ (1)	NZ513732A (pt)
PL (1)	PL199209B1 (pt)
PT (1)	PT1155013E (pt)
SK (1)	SK286710B6 (pt)
TN (1)	TNSN00031A1 (pt)
WO (1)	WO2000050418A1 (pt)
ZA (1)	ZA200106250B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6809093B2 (en)	2000-10-17	2004-10-26	H. Lee Moffitt Cancer & Research Institute, Inc.	2-substituted heterocyclic compounds
TW200303742A (en)	2001-11-21	2003-09-16	Novartis Ag	Organic compounds
US20070093485A1 (en) *	2002-12-19	2007-04-26	Elan Pharmaceuticals, Inc.	Substituted n-phenyl sulfonamide bradykinin antagonists
EP1633743A1 (en) *	2003-04-10	2006-03-15	Amgen, Inc.	Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin
EP1633348B1 (en)	2003-05-02	2008-10-08	Elan Pharmaceuticals, Inc.	4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES
US20050038099A1 (en) *	2003-05-02	2005-02-17	Tung Jay S.	Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists
US20070123531A1 (en) *	2003-05-02	2007-05-31	Elan Pharmaceuticals, Inc.	4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
SI2066659T1 (sl) *	2006-09-29	2013-10-30	Grunenthal Gmbh	Substituirani sulfonamidni derivati
TWI407960B (zh)	2007-03-23	2013-09-11	Jerini Ag	小分子緩激肽ｂ２受體調節劑
AR073304A1 (es) *	2008-09-22	2010-10-28	Jerini Ag	Moduladores del receptor de bradiquinina b2 de molecula pequena
BR112014021498A2 (pt) *	2012-02-29	2017-07-18	Institute For Hepatitis And Virus Res	composto, composição e método para tratar uma doença associada com formação de dna circular covalentemente fechado
PL3713928T3 (pl)	2017-11-24	2022-07-11	Pharvaris Netherlands B.V.	Nowi antagoniści receptora bradykininy b2
UY38706A (es) *	2019-05-23	2020-12-31	Pharvaris Gmbh	Antagonistas cíclicos del receptor b2 de bradiquinina
AR118983A1 (es)	2019-05-23	2021-11-17	Pharvaris Gmbh	Antagonistas cíclicos del receptor b2 de bradiquinina
TW202345810A (zh)	2022-03-25	2023-12-01	瑞士商帕法瑞斯有限責任公司	包含緩激肽ｂ２受體拮抗劑之固態延長釋放組成物
WO2023180577A1 (en)	2022-03-25	2023-09-28	Pharvaris Gmbh	Therapeutic uses of bradykinin b2-receptor antagonists
WO2023180575A1 (en)	2022-03-25	2023-09-28	Pharvaris Gmbh	Solid composition comprising solubilised bradykinin b2-receptor antagonists

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3617183A1 (de)	1985-11-16	1987-05-27	Bayer Ag	Substituierte benzylether
DE3632329A1 (de)	1986-09-24	1988-03-31	Bayer Ag	Substituierte phenylsulfonamide
US5202336A (en)	1986-09-24	1993-04-13	Bayer Aktiengesellschaft	Antiflammatory quinolin methoxy phenylsulphonamides
US5610140A (en)	1991-04-01	1997-03-11	Cortech, Inc.	Bradykinin receptor antagonists with neurokinin receptor blocking activity
WO1992017201A1 (en)	1991-04-01	1992-10-15	Cortech, Inc.	Bradykinin antagonists
TW258739B (pt)	1992-04-04	1995-10-01	Hoechst Ag
US5610142A (en)	1992-10-08	1997-03-11	Scios Inc.	Bradykinin antagonist pseudopeptide derivatives of substituted 4-keto-1,3,8-triazaspiro[4.5]decan-3-alkanoic acids
AU686115B2 (en)	1992-11-02	1998-02-05	Fujisawa Pharmaceutical Co., Ltd.	Imidazo (I,2-a) pyridine derivatives as bradykinin antagonists, pharmaceuticals and processes for their preparation
US5510380A (en)	1993-02-19	1996-04-23	Sterling Winthrop, Inc.	Nonpeptide bradykinin antagonists
AU680870B2 (en)	1993-04-28	1997-08-14	Astellas Pharma Inc.	New heterocyclic compounds
KR970707098A (ko)	1994-10-27	1997-12-01	후지야마 아키라	브라디키닌 길항제로서 피리도피리미돈, 퀴놀린 및 융합된 N-헤테로사이클(Pyridopyrimidones, quinolines and fused N-heterocycles as bradykinin antagonists)
JPH0940662A (ja)	1995-05-24	1997-02-10	Kyowa Hakko Kogyo Co Ltd	三環式化合物
FR2735128B1 (fr)	1995-06-07	1997-07-25	Fournier Ind & Sante	Nouveaux composes de benzenesulfonamide, leur procede de preparation et utilisation en therapeutique.
FR2737892B1 (fr)	1995-08-17	1997-10-24	Fournier Ind & Sante	Nouveaux composes de benzenesulfonamide, procede de preparation et utilisation en therapeutique
US5834431A (en)	1995-09-08	1998-11-10	Cortech, Inc.	Des-Arg9 -BK antagonists
US5849863A (en)	1995-09-08	1998-12-15	University Of Colorado	Cytolytic bradykinin antagonists
GB9519077D0 (en)	1995-09-18	1995-11-15	Fujisawa Pharmaceutical Co	New heterocyclic compounds
FR2743073B1 (fr) *	1995-12-29	1998-02-20	Fournier Ind & Sante	Nouveaux composes de 1-benzenesulfonylpyrrolidine, procede de preparation et utilisation en therapeutique
AUPN952696A0 (en)	1996-04-29	1996-05-23	Fujisawa Pharmaceutical Co., Ltd.	New heterocyclic compounds
FR2751650B1 (fr) *	1996-07-24	1998-10-09	Fournier Ind & Sante	Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique
FR2756562B1 (fr) *	1996-12-04	1999-01-08	Fournier Ind & Sante	Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique
FR2765222B1 (fr)	1997-06-27	1999-12-31	Fournier Ind & Sante	Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique

1999
- 1999-02-26 FR FR9902412A patent/FR2790260B1/fr not_active Expired - Fee Related
2000
- 2000-02-17 DK DK00906414T patent/DK1155013T3/da active
- 2000-02-17 CN CN00803551A patent/CN1340050A/zh active Pending
- 2000-02-17 EE EEP200100444A patent/EE04839B1/xx not_active IP Right Cessation
- 2000-02-17 NZ NZ513732A patent/NZ513732A/xx not_active Application Discontinuation
- 2000-02-17 BR BR0008221-0A patent/BR0008221A/pt not_active IP Right Cessation
- 2000-02-17 CZ CZ20013067A patent/CZ303169B6/cs not_active IP Right Cessation
- 2000-02-17 AT AT00906414T patent/ATE245640T1/de active
- 2000-02-17 HU HU0200281A patent/HUP0200281A3/hu unknown
- 2000-02-17 ES ES00906414T patent/ES2202059T3/es not_active Expired - Lifetime
- 2000-02-17 SK SK1192-2001A patent/SK286710B6/sk not_active IP Right Cessation
- 2000-02-17 US US09/889,965 patent/US6479515B1/en not_active Expired - Fee Related
- 2000-02-17 WO PCT/FR2000/000396 patent/WO2000050418A1/fr not_active Application Discontinuation
- 2000-02-17 PL PL350234A patent/PL199209B1/pl unknown
- 2000-02-17 EP EP00906414A patent/EP1155013B1/fr not_active Expired - Lifetime
- 2000-02-17 JP JP2000600999A patent/JP4564666B2/ja not_active Expired - Fee Related
- 2000-02-17 KR KR1020017010157A patent/KR20010102057A/ko not_active Application Discontinuation
- 2000-02-17 PT PT00906414T patent/PT1155013E/pt unknown
- 2000-02-17 DE DE60004017T patent/DE60004017T2/de not_active Expired - Lifetime
- 2000-02-17 MX MXPA01008672A patent/MXPA01008672A/es unknown
- 2000-02-17 IL IL14472000A patent/IL144720A0/xx unknown
- 2000-02-17 AU AU28096/00A patent/AU2809600A/en not_active Abandoned
- 2000-02-17 CA CA002371853A patent/CA2371853C/en not_active Expired - Fee Related
- 2000-02-17 ID IDW00200101795A patent/ID29914A/id unknown
- 2000-02-18 TN TNTNSN00031A patent/TNSN00031A1/fr unknown
- 2000-02-25 AR ARP000100812A patent/AR022754A1/es unknown
2001
- 2001-07-30 ZA ZA200106250A patent/ZA200106250B/en unknown
- 2001-08-20 NO NO20014048A patent/NO20014048D0/no not_active Application Discontinuation
- 2001-08-24 HR HR20010619A patent/HRP20010619A2/hr not_active Application Discontinuation
- 2001-08-24 BG BG105840A patent/BG105840A/xx unknown
2002
- 2002-04-23 HK HK02103040.2A patent/HK1041267A1/zh unknown

Also Published As

Publication number	Publication date
HUP0200281A2 (en)	2002-06-29
EE200100444A (et)	2002-12-16
JP4564666B2 (ja)	2010-10-20
EP1155013B1 (fr)	2003-07-23
WO2000050418A9 (fr)	2001-02-22
EE04839B1 (et)	2007-06-15
ZA200106250B (en)	2002-07-30
WO2000050418A1 (fr)	2000-08-31
SK11922001A3 (sk)	2001-12-03
NZ513732A (en)	2001-09-28
IL144720A0 (en)	2002-06-30
FR2790260B1 (fr)	2001-05-04
AR022754A1 (es)	2002-09-04
CZ303169B6 (cs)	2012-05-09
CZ20013067A3 (cs)	2001-11-14
KR20010102057A (ko)	2001-11-15
MXPA01008672A (es)	2003-06-24
SK286710B6 (sk)	2009-03-05
ID29914A (id)	2001-10-25
ES2202059T3 (es)	2004-04-01
US6479515B1 (en)	2002-11-12
AU2809600A (en)	2000-09-14
FR2790260A1 (fr)	2000-09-01
HK1041267A1 (zh)	2002-07-05
PL199209B1 (pl)	2008-08-29
CN1340050A (zh)	2002-03-13
DE60004017D1 (de)	2003-08-28
BR0008221A (pt)	2001-11-20
CA2371853C (en)	2009-09-29
TNSN00031A1 (fr)	2005-11-10
ATE245640T1 (de)	2003-08-15
EP1155013A1 (fr)	2001-11-21
BG105840A (en)	2002-04-30
DE60004017T2 (de)	2004-07-01
HRP20010619A2 (en)	2002-08-31
NO20014048L (no)	2001-08-20
DK1155013T3 (da)	2003-11-17
PL350234A1 (en)	2002-11-18
NO20014048D0 (no)	2001-08-20
CA2371853A1 (en)	2000-08-31
HUP0200281A3 (en)	2003-05-28
JP2002537392A (ja)	2002-11-05

Publication	Publication Date	Title
PT1218359E (pt)	2004-10-29	Compostos de piperazina uteis como antagonistas de taquiquininas
PT1244647E (pt)	2006-10-31	Derivados de quinazolina como inibidores de vegf
PT1216239E (pt)	2004-05-31	Derivados de piperazina como antagonistas de 5-ht1b
PT1206469E (pt)	2004-06-30	Fenil-oxazolidinonas substituidas heterociclicas antibacterianas
NO20016116D0 (no)	2001-12-14	Substituerte heterocykliske fuserte gamma-karboliner
DE60032601D1 (de)	2007-02-08	Als antikrebsmittel verwendbare heterocyklische derivate
PT1084114E (pt)	2004-12-31	Derivados isotiazole uteis como agentes anticancerigenos
PT1198453E (pt)	2003-08-29	Derivados de n-(indolcarbonil)-piperazina como ligandos do receptor 5-ht2a
EE200100393A (et)	2002-10-15	Vähivastaste vahenditena kasulikud asendatud bitsüklilised derivaadid
PT1287001E (pt)	2004-12-31	Derivados de tiofeno uteis como agentes anticancerigenos
AR028280A1 (es)	2003-04-30	Derivados de 2-amino-3-(alquil)-pirimidona
PT1155013E (pt)	2003-12-31	Compostos heterociclicos de benzenossulfonamida como antagonistas da bradiquinina
DK1218382T3 (da)	2004-03-22	Bicykliske imidazo-3-ylaminderivater
PT1212320E (pt)	2005-11-30	Fenilpiperazinas como inibidores de reabsorcao de serotonina
AR027967A1 (es)	2003-04-16	Derivados de esteres de pirazol como agentes antinflamatorios/analgesicos
PT1163239E (pt)	2003-10-31	Amidas de aminoacidos modificadas como antagonistas do cgrp
PT1226131E (pt)	2004-05-31	Derivados de isoxazolecarboxamida como antagonistas do receptor adrenergico alfa1
DE50015443D1 (de)	2008-12-18	Bicyclische imidazo-5-yl-aminderivate
PT1178986E (pt)	2004-07-30	Derivados da furanona como inibidores da catepsina s
MXPA03001848A (es)	2003-06-04	Derivados de fenoxibencilamina como inhibidores de la reabsorcion de serotonina.
PT1216250E (pt)	2004-04-30	Derivados propilicos substituidos de tienoisoxazolil- e tienilpirrazolil-fenoxi uteis como antagonistas d4
DZ3244A1 (fr)	2001-06-28	Inhibiteurs de 8-arylquinoline phosphodiesterase-4 substituee
PT1360184E (pt)	2005-06-30	Derivados de piperidina como antagonistas da neuroquinina 1
PT1189907E (pt)	2005-05-31	Tienopirimidinas como inibidores da fosfodiesterase
PT1171419E (pt)	2005-04-29	Derivados de bifenilo como antagonistas do receptor da neuroquinina-1